A reactor operator retrieves a sample can from the MURR, as seen from above. (Photo: University of Missouri)
The University of Missouri announced today that it has signed a $10 million contract for the initial design phase of the $1 billion-plus state-of-the-art NextGen MURR research reactor project.
Concept art of NANO Nuclear’s KRONOS MMR research reactor that UIUC plans to operate on its campus in Champaign, Ill. (Image: NANO Nuclear)
Plans to bring a university research reactor like no other to the campus of the University of Illinois at Urbana-Champaign (UIUC) were punctuated last fall by the news that Ultra Safe Nuclear, the developer of the gas-cooled reactor technology selected for the Illinois Microreactor Project, had declared bankruptcy.
DPSC blocks undergo testing at Purdue University’s Bowen Laboratory. (Photo: Idaho National Laboratory)
Researchers at GE Hitachi Nuclear recently completed a successful test on potential new building blocks made of steel-concrete composite.
Historic nuclear plant restart could happen in 2025.
Palisades nuclear power plant on Lake Michigan, at night. (Photo: Holtec)
Mike Mlynarek believes in this expression: “In the end it will be OK; and if it’s not OK, it’s not the end.”
As the site vice president at Palisades nuclear power plant in Covert Township, Mich., Mlynarek is overseeing one of the most exciting projects in the United States nuclear power industry. If all goes according to plan, Holtec’s Palisades plant will be splitting atoms once again by the end of 2025 and become the first U.S. nuclear facility to restart after being slated for decommissioning.
Industry's first lead test assemblies with U-235 enriched up to 6 percent were loaded into Vogtle-2. (Photo: Southern Nuclear)
Southern Nuclear recently loaded nuclear fuel with uranium-235 enriched up to 6 percent—higher than the usual 3–5 percent enrichment—into Vogtle-2 to test it through irradiation.
January 24, 2025, 3:09PMUpdated April 9, 2025, 2:58PMNuclear NewsMatt Wald (Photo: Used with permission from Constellation)
When Exelon Generation shut down Three Mile Island Unit 1 in September 2019, managers were so certain that the reactor would never run again that as soon as they could, they had workers drain the oil out of both the main transformer and a spare to eliminate the chance of leaks. The company was unable to find a buyer because of the transformers’ unusual design. “We couldn’t give them away,” said Trevor Orth, the plant manager. So they scrapped them.
Now they will pay $100 million for a replacement.
The turnaround at the reactor—now called the Crane Clean Energy Center—highlights two points: how smart Congress was to step in with help to prevent premature closures with the zero-emission nuclear power production credit of 0.3 cents per kilowatt-hour (only two years too late), and how expensive it is turning out to be to change course.
On track to be the first SMR constructed in North America
During a November 2024 mission, the IAEA delivered two new ambulances to Ukraine at the Chernobyl site. Varash Hospital director Tetiana Latyshenko is at left, with Liliana Salaru, IAEA senior medical officer, at right. (Photo: IAEA)
The United Nations' nuclear watchdog delivered emergency medical supplies to Ukraine last week as part of ongoing aid to the country since its conflict with Russia began in 2022.
William D. Magwood IV (left) meets with government officials during a visit to Mongolia. (Photo: NEA)
Nuclear Energy Agency Director General William D. Magwood IV visited Mongolia recently for a series of meetings with government representatives and to participate in discussions on nuclear energy development in the country.
At-211 undergoes purification and a series of quality checks. (Photo: Don Hamlin/University of Washington)
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”